CUE - Cue Biopharma GAAP EPS of -$0.44 misses by $0.02 revenue of $1M misses by $1.92M May, 10 2022 05:03 PM Cue Biopharma Inc. Cue Biopharma press release (NASDAQ:CUE): Q1 GAAP EPS of -$0.44 misses by $0.02. Revenue of $1M (-35.5% Y/Y) misses by $1.92M. For further details see: Cue Biopharma GAAP EPS of -$0.44 misses by $0.02, revenue of $1M misses by $1.92M